Cargando…
Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses
BACKGROUND: The COVID-19 pandemic continues to cause morbidity and mortality worldwide. Most approved COVID-19 vaccines generate a neutralizing antibody response that primarily targets the highly variable receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein. SARS-CoV-2 “variants of conc...
Autores principales: | Halfmann, Peter J., Frey, Steven J., Loeffler, Kathryn, Kuroda, Makoto, Maemura, Tadashi, Armbrust, Tammy, Yang, Jie E., Hou, Yixuan J., Baric, Ralph, Wright, Elizabeth R., Kawaoka, Yoshihiro, Kane, Ravi S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651965/ https://www.ncbi.nlm.nih.gov/pubmed/36375316 http://dx.doi.org/10.1016/j.ebiom.2022.104341 |
Ejemplares similares
-
Potent neutralization of SARS‐CoV‐2 including variants of concern by vaccines presenting the receptor‐binding domain multivalently from nanoscaffolds
por: Halfmann, Peter J., et al.
Publicado: (2021) -
Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization
por: Chiba, Shiho, et al.
Publicado: (2021) -
Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages
por: Maemura, Tadashi, et al.
Publicado: (2021) -
Broad Protection Against Clade 1 Sarbecoviruses After a Single Immunization with Cocktail Spike-Protein-Nanoparticle Vaccine
por: Halfmann, Peter J., et al.
Publicado: (2023) -
Protective Immunity and Persistent Lung Sequelae in Domestic Cats after SARS-CoV-2 Infection
por: Chiba, Shiho, et al.
Publicado: (2021)